• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality.

作者信息

Viayna Elisabet, Gehrie Eric A, Blanchette Christopher, Meny Geralyn M, Noumsi Ghislain, Huber Maria, Runken M Chris

机构信息

Grifols S.A. Sant Cugat del Vallès, Barcelona, Spain.

American Red Cross, Washington, DC.

出版信息

Blood Adv. 2022 Oct 25;6(20):5655-5658. doi: 10.1182/bloodadvances.2022006982.

DOI:10.1182/bloodadvances.2022006982
PMID:35939787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9582716/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b96/9582716/a8549161fa7a/BLOODA_ADV-2022-006982-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b96/9582716/a8549161fa7a/BLOODA_ADV-2022-006982-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b96/9582716/a8549161fa7a/BLOODA_ADV-2022-006982-gr1.jpg

相似文献

1
Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality.红细胞同种免疫与医疗费用增加、住院时间延长和死亡率升高有关。
Blood Adv. 2022 Oct 25;6(20):5655-5658. doi: 10.1182/bloodadvances.2022006982.
2
Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.前瞻性红细胞抗原匹配预防镰状细胞病患者同种免疫的成本效益。
Transfusion. 2014 Jan;54(1):86-97. doi: 10.1111/trf.12250. Epub 2013 May 21.
3
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.红细胞同种免疫与骨髓增生异常综合征自身抗体的产生和红细胞输注需求增加有关。
Haematologica. 2017 Dec;102(12):2021-2029. doi: 10.3324/haematol.2017.175752. Epub 2017 Oct 5.
4
Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.多次输注 RhD 阳性含主型红细胞制品后 RhD 同种免疫的发生率。
Transfusion. 2021 Jul;61 Suppl 1:S150-S158. doi: 10.1111/trf.16495.
5
Transfusion-Related Alloimmunization to Red Blood Cell Antigens in Japanese Pediatric Recipients.日本儿科受血者红细胞抗原相关同种免疫
Transfus Med Rev. 2021 Jan;35(1):29-36. doi: 10.1016/j.tmrv.2020.09.001. Epub 2020 Sep 10.
6
Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.红细胞抗原匹配对镰状细胞病患者同种免疫和输血并发症的影响：系统评价。
Transfus Med Rev. 2019 Jan;33(1):12-23. doi: 10.1016/j.tmrv.2018.07.003. Epub 2018 Jul 26.
7
Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.红细胞同种免疫对镰状细胞病死亡率的影响：病例系列研究
Transfusion. 2016 Jan;56(1):107-14. doi: 10.1111/trf.13379. Epub 2015 Oct 28.
8
Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization.与实体癌的治疗方法相比，血液系统恶性肿瘤的治疗与红细胞同种免疫减少有关。
Haematologica. 2017 Jan;102(1):52-59. doi: 10.3324/haematol.2016.152074. Epub 2016 Sep 15.
9
Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.镰状细胞病患者红细胞同种免疫的早期发生。
Am J Hematol. 2016 Aug;91(8):763-9. doi: 10.1002/ajh.24397. Epub 2016 May 24.
10
Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization.对于母体红细胞同种免疫，大容量、较少频率的宫内红细胞输血的优势。
Am J Perinatol. 1996 Jan;13(1):27-33. doi: 10.1055/s-2007-994198.

引用本文的文献

1
CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion.CD47在不相容输血后调节抗原调节和红细胞清除。
Front Immunol. 2025 Apr 4;16:1548548. doi: 10.3389/fimmu.2025.1548548. eCollection 2025.
2
Dynamics of antibody engagement of red blood cells and .红细胞抗体结合的动力学及…… （原文似乎不完整）
Front Immunol. 2024 Nov 28;15:1475470. doi: 10.3389/fimmu.2024.1475470. eCollection 2024.
3
Longitudinal outcomes of chronically transfused adults with sickle cell disease and a history of childhood stroke.

本文引用的文献

1
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.美国血液学会 2020 年镰状细胞病指南：输血支持。
Blood Adv. 2020 Jan 28;4(2):327-355. doi: 10.1182/bloodadvances.2019001143.
2
Blood group genotyping.血型基因分型。
Blood. 2019 Apr 25;133(17):1814-1820. doi: 10.1182/blood-2018-11-833954. Epub 2019 Feb 26.
3
Transfusion-related red blood cell alloantibodies: induction and consequences.输血相关红细胞同种抗体：诱导与后果。
患有镰状细胞病且有儿童期卒中病史的长期接受输血的成年人的纵向转归。
Transfusion. 2024 Dec;64(12):2260-2269. doi: 10.1111/trf.18041. Epub 2024 Nov 5.
4
ABO blood groups and galectins: Implications in transfusion medicine and innate immunity.ABO 血型与半乳糖凝集素：在输血医学和天然免疫中的意义。
Semin Immunol. 2024 Jul-Sep;74-75:101892. doi: 10.1016/j.smim.2024.101892. Epub 2024 Oct 14.
5
Standard Compared With Extended Red Blood Cell Antigen Matching for Prevention of Subsequent Hemolytic Disease of the Fetus and Newborn: A Systematic Review.标准红细胞抗原匹配与扩展红细胞抗原匹配预防胎儿及新生儿溶血病的比较：一项系统评价
Obstet Gynecol. 2024 Oct 1;144(4):444-453. doi: 10.1097/AOG.0000000000005701. Epub 2024 Aug 8.
6
Maternal red blood cell alloimmunization prevalence in the United States.美国母婴红细胞同种免疫的流行率。
Blood Adv. 2024 Aug 27;8(16):4311-4319. doi: 10.1182/bloodadvances.2023012241.
7
Future prospects for the clinical transfusion of pig red blood cells.猪红细胞临床输注的前景展望。
Blood Rev. 2023 Sep;61:101113. doi: 10.1016/j.blre.2023.101113. Epub 2023 Jul 14.
Blood. 2019 Apr 25;133(17):1821-1830. doi: 10.1182/blood-2018-08-833962. Epub 2019 Feb 26.
4
Transfusion service knowledge and immunohaematological practices related to sickle cell disease and thalassemia.与镰状细胞病和地中海贫血相关的输血服务知识及免疫血液学实践。
Transfus Med. 2019 Jun;29(3):185-192. doi: 10.1111/tme.12580. Epub 2019 Feb 10.
5
The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: a 10-year experience at a tertiary care hospital.地中海贫血输血的患病率、同种免疫危险因素、抗原暴露及抗原匹配红细胞的评估：一家三级医疗医院的10年经验
Transfusion. 2019 Jan;59(1):177-184. doi: 10.1111/trf.15002. Epub 2018 Nov 15.
6
Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.红细胞抗原匹配对镰状细胞病患者同种免疫和输血并发症的影响：系统评价。
Transfus Med Rev. 2019 Jan;33(1):12-23. doi: 10.1016/j.tmrv.2018.07.003. Epub 2018 Jul 26.
7
Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline.血红蛋白病患者的红细胞规格：系统评价与指南
Transfusion. 2018 Jun;58(6):1555-1566. doi: 10.1111/trf.14611. Epub 2018 Apr 26.
8
Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.成人镰状细胞病患者迟发性溶血性输血反应的发生率和预测评分。
Am J Hematol. 2017 Dec;92(12):1340-1348. doi: 10.1002/ajh.24908. Epub 2017 Oct 31.
9
Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.镰状细胞病中预防同种免疫策略的医学及经济影响
Transfusion. 2017 Sep;57(9):2267-2276. doi: 10.1111/trf.14212. Epub 2017 Jun 26.
10
Consider the source: the importance of including all transfused products and exposures in red blood cell alloimmunization research.考虑其来源：在红细胞同种免疫研究中纳入所有输注产品和暴露情况的重要性。
Transfusion. 2016 Feb;56(2):290-3. doi: 10.1111/trf.13470.